Did you mean
divergent

Search results - 17 results

Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.

acid extraction and PCR inhibition are included in the assay. Clinical performance of OncoPredict HPV QT test was assessed as part of the “Validation of HPV Genotyping Tests” (VALGENT-2) framework, ...

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.

ImmunoAssay (GP5 +/6+ EIA) using the VALGENT (VAL idation of HPV GEN otyping Tests) framework. METHODS: Clinical performance was assessed using 998 unselected, cervical screening samples enriched with 297 ...

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework

Kate; M. Arbyn Source: Journal of Medical Virology, Volume 95, Issue 1 (2023) Keywords: cervical cancer HPV genotyping human papillomavirus OncoPredict HPV® test validation. VALGENT Abstract: Human ...

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.

efficiency and PCR inhibition. 1300 VALGENT-2 study samples (from women aged 20-60 attending the Scottish cervical cancer screening program) were tested with the index assay and the GP5 +/6+ PCR enzyme ...

Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework

clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests. In the VALGENT-3 study, the clinical accuracy of the ...

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.

Cervical Neoplasms Abstract: In 2012, VAL idation of human papillomavirus (HPV) GEN otyping T ests (VALGENT) was initiated to provide a formalized and uniform study framework for comparison and validation of ...

Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.

(hrHPV) types is more effective than cytology-based screening. This study completes the diagnostic accuracy assessment conducted previously within the framework of VALGENT-2 (Validation of HPV genotyping ...

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

Neoplasms Abstract: In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. ...

Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.

Abstract: Human papillomavirus (HPV) testing is being increasingly incorporated into cervical cancer screening. VALGENT (VAL idation of HPV GEN otyping Tests) is a framework designed to evaluate the clinical ...

Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests).

(VALGENT) studies offer an opportunity to clinically validate HPV assays for use in primary screening for cervical cancer and also provide a framework for the comparison of analytical and type-specific ...

QR code

QR code for this page URL